Treatment of Serous-Exudative Retinal Detachment Caused by Intraocular Melanoma

Serous-exudative retinal detachment is a non-rhegmatogenous form in which fluid accumulates beneath the retina due to an underlying cause rather than a retinal tear. When intraocular melanoma is identified as the driving pathology, the clinical approach is directed at the tumour itself.

Clinical scenario: Serous-exudative retinal detachment in a patient with intraocular melanoma. In this setting, management centres on treating the causative intraocular tumour — the retinal detachment is a secondary consequence of the melanoma rather than a primary retinal event.

Treatment approach: The protocol for this scenario involves a targeted form of radiotherapy directed at the intraocular tumour. The complete regimen — including selection criteria, sequencing, and follow-up — is available in the full protocol. Full regimen details, dosing, and clinical algorithm available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/S1060-135X(98)90029-X

Serous-exudative RD is usually treated by ascertaining and treating the cause.

If the cause is posterior scleritis, the treatment may be systemic steroids or nonsteroidal antiinflammatory drugs; if Vogt-Koyanagi-Harada syndrome, the treatment may be systemic steroids; if intraocular melanoma, the treatment may be iodine 125 plaque radiotherapy; and if intraocular metastatic tumors, the treatment may be external beam irradiation.

View source ↗